Respiratory epithelial adenomatoid hamartoma with nasal polyps affects dupilumab efficacy. Takeda T, Yanagi N, Fukasawa N, Mori E, et al. Rhinology 2022;60:148-151.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Takeda T, Yanagi N, Fukasawa N, Mori E, et al. Respiratory epithelial adenomatoid hamartoma with nasal polyps affects dupilumab efficacy. Rhinology 2022;60:148-151.
PMID: 35174813